Requena-Méndez Ana, Salas-Coronas Joaquin, Salvador Fernando, Gomez-Junyent Joan, Villar-Garcia Judith, Santin Miguel, Muñoz Carme, González-Cordón Ana, Cabezas Fernández Maria Teresa, Sulleiro Elena, Arenas Maria Del Mar, Somoza Dolors, Vazquez-Villegas Jose, Treviño Begoña, Rodríguez Esperanza, Valls Maria Eugenia, LLaberia-Marcual Jaume, Subirá Carme, Muñoz Jose
Barcelona Institute for Global Health, ISGlobal-Hospital Clinic, Universitat de Barcelona, 08036 Barcelona, Spain.
Department of Global Public Health, Karolinska Institutet, 171 77 Solna, Sweden.
Pathogens. 2020 Feb 11;9(2):107. doi: 10.3390/pathogens9020107.
: Strongyloidiasis is a prevailing helminth infection ubiquitous in tropical and subtropical areas, however, seroprevalence data are scarce in migrant populations, particularly for those coming for Asia. : This study aims at evaluating the prevalence of at the hospital level in migrant populations or long term travellers being attended in out-patient and in-patient units as part of a systematic screening implemented in six Spanish hospitals. A cross-sectional study was conducted and systematic screening for infection using serological tests was offered to all eligible participants. : The overall seroprevalence of was 9.04% (95%CI 7.76-10.31). The seroprevalence of people with a risk of infection acquired in Africa and Latin America was 9.35% (95%CI 7.01-11.69), 9.22% (7.5-10.93), respectively. The number of individuals coming from Asian countries was significantly smaller and the overall prevalence in these countries was 2.9% (95%CI -0.3-6.2). The seroprevalence in units attending potentially immunosuppressed patients was significantly lower (5.64%) compared with other units of the hospital (10.20%) or Tropical diseases units (13.33%) ( < 0.001). : We report a hospital-based strongyloidiasis seroprevalence of almost 10% in a mobile population coming from endemic areas suggesting the need of implementing strongyloidiasis screening in hospitalized patients coming from endemic areas, particularly if they are at risk of immunosuppression.
类圆线虫病是一种在热带和亚热带地区普遍存在的蠕虫感染,但关于移民人群,尤其是来自亚洲的移民人群的血清流行率数据却很稀少。本研究旨在评估在六家西班牙医院实施的系统筛查中,门诊和住院部接待的移民人群或长期旅行者中类圆线虫病的医院层面流行率。进行了一项横断面研究,并为所有符合条件的参与者提供了使用血清学检测进行类圆线虫感染的系统筛查。类圆线虫病的总体血清流行率为9.04%(95%置信区间7.76 - 10.31)。在非洲和拉丁美洲感染风险人群中的血清流行率分别为9.35%(95%置信区间7.01 - 11.69)、9.22%(7.5 - 10.93)。来自亚洲国家的个体数量明显较少,这些国家的总体流行率为2.9%(95%置信区间 - 0.3 - 6.2)。与医院其他科室(10.20%)或热带病科室(13.33%)相比,接待潜在免疫抑制患者的科室的血清流行率显著更低(5.64%)(P < 0.001)。我们报告了在来自流行地区的流动人群中,基于医院的类圆线虫病血清流行率近10%,这表明有必要对来自流行地区的住院患者开展类圆线虫病筛查,特别是如果他们有免疫抑制风险。